Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.18
Delayed Data
As of 10:49am ET
 +0.03 / +0.33%
Today’s Change
6.90
Today|||52-Week Range
9.88
+7.12%
Year-to-Date

Today’s Trading

Previous close9.15
Today’s open9.22
Day’s range9.10 - 9.22
Volume62,955
Average volume (3 months)356,297
Market cap$725.0M
Dividend yield--
Data as of 10:49am ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+18.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
KANGiKang Healthcare Gro...-0.02-0.16%
ENZEnzo Biochem Inc-0.03-0.26%
NTRANatera Inc+0.04+0.41%
NVTAInvitae Corp-0.02-0.21%
Data as of 11:05am ET, 07/21/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts